insecticide „pix ecto vet“ unguenta 2 % / 100 g маз
ФАРМА ВЕТ ООД - Боровата Катран - маз - 2 % / 100 g - кучета
pergoquin 1 mg таблетки за коне
richter pharma ag - Перголида - таблетка - 1.0 mg/таблетка - коне
insulin aspart sanofi
sanofi winthrop industrie - инсулин аспарт - Захарен диабет - Лекарства, използвани при диабет - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
alphadoxan 100 mg/g premix for medicated feeding stuff for pigs 100 mg/g
alpha-vet veterinary ltd. - Доксициклин - премикс за медикаментозен фураж - 100 mg/g - свине
kirsty (previously kixelle)
biosimilar collaborations ireland limited - инсулин аспарт - Захарен диабет - Лекарства, използвани при диабет - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
alphaflorovet 20 mg/g premix for medicated feeding stuff for pigs 20 mg/g
alpha-vet veterinary ltd. - Флорфеникол - премикс за медикаментозен фураж - 20 mg/g - прасета
amversio
serb sa - betaine - Хомоцистинурията - Други стомашно-чревния тракт и обмяната на веществата средства, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:• cystathionine beta-synthase (cbs),• 5,10 methylene tetrahydrofolate reductase (mthfr),• cobalamin cofactor metabolism (cbl).
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - Меланомът - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
imjudo
astrazeneca ab - tremelimumab - carcinoma, hepatocellular - Антинеопластични средства - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.
tremelimumab astrazeneca
astrazeneca ab - tremelimumab - Карцином, недребноклетъчен белодроб - Антинеопластични средства - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.